Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Harris

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|June 21, 2017
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatmentRichard Kim, E Gabriela Chiorean, Manik Amin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2014
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinomaKimberly J Riehle, Matthew M Yeh, Jeannette J Yu, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 6, 2013
Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particlesSiddharth A Padia, Giri Shivaram, Sarah Bastawrous, et al.
Annals of Diagnostic Pathology|April 2, 2021
S100P as a marker for poor survival and advanced stage in gallbladder carcinomaAlka Mary Mathai, Jacob Alexander, Hsuan-Ying Huang, et al.
The Oncologist|February 7, 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular CarcinomaShawn Yu, Menggang Yu, Barry Keane, et al.
Current Problems in Diagnostic Radiology|May 13, 2021
Is There a Difference Between LI-RADS 3 to LI-RADS 5 Progression Assessment Using CT Versus MR? A Retrospective, Single-Center, Longitudinal Study of Patients Who Underwent 5082 Radiologic Examinations for Surveillance of Hepatocellular Carcinoma Over a 43-Month PeriodPatricia I Ojeda, Lindsay M Hannan, Rebecca J Mieloszyk, et al.
World Journal of Hepatology|June 19, 2015
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experienceMatthew M Yeh, Raymond S Yeung, Smith Apisarnthanarax, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 3, 2017
Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched StudySiddharth A Padia, Guy E Johnson, Kathryn J Horton, et al.
Therapeutic Advances in Medical Oncology|November 20, 2024
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter studyMichael Li, Lindsay M Hannan, Lipika Goyal, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|June 21, 2017
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatmentRichard Kim, E Gabriela Chiorean, Manik Amin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2014
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinomaKimberly J Riehle, Matthew M Yeh, Jeannette J Yu, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 6, 2013
Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particlesSiddharth A Padia, Giri Shivaram, Sarah Bastawrous, et al.
Annals of Diagnostic Pathology|April 2, 2021
S100P as a marker for poor survival and advanced stage in gallbladder carcinomaAlka Mary Mathai, Jacob Alexander, Hsuan-Ying Huang, et al.
The Oncologist|February 7, 2024
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular CarcinomaShawn Yu, Menggang Yu, Barry Keane, et al.
Current Problems in Diagnostic Radiology|May 13, 2021
Is There a Difference Between LI-RADS 3 to LI-RADS 5 Progression Assessment Using CT Versus MR? A Retrospective, Single-Center, Longitudinal Study of Patients Who Underwent 5082 Radiologic Examinations for Surveillance of Hepatocellular Carcinoma Over a 43-Month PeriodPatricia I Ojeda, Lindsay M Hannan, Rebecca J Mieloszyk, et al.
World Journal of Hepatology|June 19, 2015
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experienceMatthew M Yeh, Raymond S Yeung, Smith Apisarnthanarax, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 3, 2017
Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched StudySiddharth A Padia, Guy E Johnson, Kathryn J Horton, et al.
Therapeutic Advances in Medical Oncology|November 20, 2024
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter studyMichael Li, Lindsay M Hannan, Lipika Goyal, et al.
Pageof 4